Suppr超能文献

烟酰胺在体外可抑制恶性疟原虫Sir2活性及寄生虫生长。

Nicotinamide inhibits Plasmodium falciparum Sir2 activity in vitro and parasite growth.

作者信息

Prusty Dhaneswar, Mehra Parul, Srivastava Sandeep, Shivange Amol V, Gupta Ashish, Roy Nilanjan, Dhar Suman Kumar

机构信息

Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India.

出版信息

FEMS Microbiol Lett. 2008 May;282(2):266-72. doi: 10.1111/j.1574-6968.2008.01135.x. Epub 2008 Apr 2.

Abstract

Plasmodium falciparum sirtuin, PfSir2, contains histone deacetylase (HDAC) activity that may be central to the regulation of virulence gene expression in the parasites. Although a few reports have been published recently regarding in vitro and in vivo function of PfSir2, expression of the endogenous protein (c. 30 kDa) has not been shown yet. Here we report the presence of PfSir2 in the parasite at the protein level by specific antibodies. HDAC activity of PfSir2 can be inhibited by nicotinamide, a product of sirtuin reaction. Surprisingly, we find that nicotinamide also delays parasite growth significantly in culture. These findings further our knowledge on PfSir2 and raise the possibility of using an inexpensive agent like nicotinamide as an antimalarial in combination with other antiparasitic drugs.

摘要

恶性疟原虫沉默信息调节因子2(PfSir2)具有组蛋白去乙酰化酶(HDAC)活性,这可能是该寄生虫毒力基因表达调控的核心。尽管最近有几篇关于PfSir2体外和体内功能的报道,但内源性蛋白(约30 kDa)的表达尚未得到证实。在此,我们通过特异性抗体在蛋白质水平报告了PfSir2在疟原虫中的存在。PfSir2的HDAC活性可被烟酰胺(一种沉默信息调节因子反应的产物)抑制。令人惊讶的是,我们发现烟酰胺在培养中也能显著延缓疟原虫的生长。这些发现进一步拓展了我们对PfSir2的认识,并增加了将烟酰胺这种廉价药物与其他抗寄生虫药物联合用作抗疟药的可能性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验